| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.091 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |